
Next-generation imaging technology for nuclear medicine.
Terapet SA,, a CERN spin-off in MedTech, was incorporated in Geneva, Switzerland on 19.12.2019. The founders are two CERN physicists, Dr. Christina Vallgren (PhD in Applied Physics, MSc in Nuclear Physics and MBA), Dr. Marcus Palm (PhD in Applied Physics, MSc in Engineering Physics and Electronics) and a leading radiation oncologist, Prof. Raymond Miralbell (Radiation Oncologist 40+ years). Terapets core technology is an innovative platform technology for imaging in nuclear medicine and radiotherapy. On June 13, 2025, Terapet SA successfully achieved ISO 13485:2016 certificationa major milestone that underscores the companys commitment to innovation, quality, regulatory compliance, and, ultimately, improved patient care.



